Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 524632 | NSE Symbol : | ISIN : INE551C01044 | Industry : Pharmaceuticals - Indian - Formulations |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
29-Mar-2025	29-Mar-2025	Change in Auditors	Intimation of change in Secretarial Auditor of the company
26-Mar-2025	26-Mar-2025	Others	Outcome of the meeting of Independent directors held on today to consider the agendas as attached.
03-Feb-2025	14-Feb-2025	Quarterly Results	Shukra Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 inter alia to consider and approve The Un-audited Financial Results of the Company for the Third quarter and Nine months ended on 31st December 2024 of the current financial year 2024-25 pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015. Outcome of Board Meeting held today i.e. on 14th February, 2025 and 1. submission of Un-audited Financial Results of the Company for the Quarter and Nine months ended on 31st December, 2024. 2. Appointment Mr. Jay Gandhi, as Internal Auditor for FY 2024-25, The brief information as required under Regulation 30 of SEBI (LODR) regulations, 2015 for the said matter is attached as 'Annexure A'. 3. Appointment of Ms. Shilpa Shah (Practising Company Secretary), as Secretarial Auditor for FY 2024-25, The brief information as required under Regulation 30 of SEBI (LODR) regulations, 2015 for the said matter is attached as 'Annexure B'. (As Per BSE Announcement Dated on 14.02.2025)
24-Jan-2025	29-Jan-2025	Stock Split	Shukra Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/01/2025 inter alia to consider and approve Subdivision/ Stock Split of Equity Shares of the Company subject to approval of the shareholders the Company and other necessary approvals Outcome of Board Meeting held today i.e. on January 29, 2025 pursuant to Regulation 30 of SEBI (Listing and Obligations and Disclosure Requirements) Regulations, 2015 (As Per BSE Announcement Dated on: 29/01/2025)
04-Jan-2025	09-Jan-2025	Right Issue	Shukra Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/01/2025 inter alia to consider and approve To offer and issue of equity shares of the Company by way of a rights issue to eligible shareholders of the Company as on the record date (to be decided at a later date) for an amount not exceeding ? 36 crore in accordance with the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations 2018 as amended and other applicable laws (the 'Rights Issue'). In connection with our earlier correspondence dated 4th January, 2025 wherein the Company intimated about the Board meeting scheduled to be held on Thursday, 9th January, 2025, we would like to inform the Exchange and all Stakeholders that certain matters, including the matters relating to Right Issue which were originally scheduled to be transacted at the ensuing Board meeting have now been deferred for being considered by the Board. The Company will intimate in due course and in accordance with the SEBI LODR regulations about the date of the Board meeting at which the offer and issue of equity shares of the Company, will be considered. (As Per BSE Announcement Dated on: 09/01/2025)
07-Nov-2024	14-Nov-2024	Quarterly Results	Shukra Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve Intimation of Board Meeting under Regulation 29 and 33 of SEBI (LODR) Regulations 2015 to be held on Thursday 14th November 2024 To consider and approve the Un-audited Financial Results of the Company For the Second Quarter and half year ended on 30th September 2024 ol the current F.Y 2024-25 pursuant to Regulation 33 of the SEBI (LODR) Regulations 2015. Outcome of Board Meeting held today i.e. on 14th November, 2024 and submission of Un-audited Financial Results of the Company for the Second Quarter and Half Year ended on 30th September, 2024. (As per BSE Announcement Dated on 14/11/2024)
25-Oct-2024	25-Oct-2024	Change in Directors	APPOINTMENT OF SHEETAL SHAH AS DIRECTOR AND RITU KAPOOR AS INDEPENDENT DIRECTOR IN THE MEETING HELD ON FRIDAY, OCTOBER 25, 2024.
23-Sep-2024	28-Sep-2024	Right Issue	Shukra Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/09/2024 inter alia to consider and approve Shukra Pharmaceuticals Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on Saturday September 28 2024. Board meeting conducted to consider rights issue and approve the draft offer letter Board meeting conducted to consider and approve Rights issues and approve draft offer letter to consider and approve right issue and approve draft offer letter (As per BSE Announcement Dated on 28/09/2024)
03-Aug-2024	12-Aug-2024	Quarterly Results	Shukra Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2024 inter alia to consider and approve unaudited financial results for the quarter ended June 30 2024 Approval of Financial results for the quarter ended June 30, 2024 (As Per Bse Announcement Dated on 12.08.2024)
23-Jul-2024	23-Jul-2024	Increase in Authorised Capital	Increase in the authorised share capital of company.
10-Jul-2024	10-Jul-2024	Change in Directors	Resignation of Mr. Mehul Patel from the post of Chief Financial Officer of the Company with effect from July 10, 2024, Appointment of Ms. Anar Jayesh Patel (DIN: 02588388 ), as Additional Director (Whole-time Director), liable to retire by rotation, designated as Executive Director for a period of 5 years with effect from July 10, 2024 to July 09, 2029 and appointment of Mr. Jitendra Somchand Shah ( DIN: 01609325), as an Additional Director categorized as Non - Executive Independent Director of the Company, for a term of 5 consecutive years w.e.f. July 10, 2024 to July 9 2029
18-May-2024	29-May-2024	Accounts	Shukra Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 inter alia to consider and approve Pursuant to Regulation 29 read with other applicable Regulation of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that the Meeting of the Board of Directors of the Company is scheduled to be held on 29th May 2024 Wednesday at the Registered Office of the Company inter alia to consider and approve the following: - 1. To Consider Adopt and Approve Audited financial result for the quarter and financial year ended on 31st March 2024 2. Recommend final dividend to the members of the company for the financial year 2023-24 3. Any other business with the permission of Chairman. In terms of the Companys Code of Conduct for Prevention of Insider Trading the Trading Window for dealing in securities of the Company has been closed from 1ST April 2024 till the end of 48 hours after the declaration of the Financial Results of the Company for the quarter and financial year ended on March 31 2024. With Reference to the subject, the board of directors of the company has recommended the dividend of Rs. 1/- that is 10% per equity share of Rs. 10/- each for the financial year 2023-24. (As Per BSE Announcement dated on 29.05.2024)
25-Apr-2024	25-Apr-2024	Bonus Issue	The Company is informing the exchange about allotment of bonus shares The Company has received approval from shareholders to issue bonus shares through postal ballot on April 03rd 2024 and the BSE In Principle approval received on 18th March, 2024 bearing letter no: LOD/Bonus/BN-IP/TT/1444/2023-24. The Board of Directors in their meeting held today has approved allotment of 3,28,40,958 shares having face value of Rs. 10/-(Rupees Ten Only) each in ratio of 3(Three) new Equity shares for every 1(One) Equity shares held by the shareholders as on record date i.e. 20th April, 2024.
06-Apr-2024	06-Apr-2024	Bonus Issue	The Board of directors has April 20, 2024 as record date.
16-Mar-2024	28-Mar-2024	Others	Intimation of the independent directors meeting to be held on 28th March, 2024. Outcome of meeting of Independent Directors of the company. (As per BSE Announcement Dated on 28/03/2024)

1 2 3 Next

LOGIN HERE

Shukra Pharmaceuticals Ltd

Board Meeting